Clinical Focus ›› 2023, Vol. 38 ›› Issue (4): 377-380.doi: 10.3969/j.issn.1004-583X.2023.04.017
Previous Articles Next Articles
-
Received:2022-11-28Online:2023-04-20Published:2023-06-06
CLC Number:
Cite this article
share this article
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2023.04.017
| [1] | Global initiative for chronic obstructive lung disease. Global strategy for prevention, diagnosis, and management of COPD (2021 REPORT)[EB/OL]. https://goldcopdorg/2021-gold-reports/, 2021-11-17. |
| [2] | World Health Organization Burden of COPD. The top 10 causes of death[EB/OL]. https://wwwwhoint/zh/news-room/fact-sheets/detail/the-top-10-causes-of-death, 2021-11-17. |
| [3] |
Miravitlles M, Calle M, Molina J, et al. Spanish COPD guidelines (GesEPOC): Pharmacological treatment of stable COPD[J]. Aten Primaria, 2012, 44(7):425-437.
doi: 10.1016/j.aprim.2012.04.005 URL |
| [4] | Zbozinkova Z, Barczyk A, Tkacova R, et al. POPE study: Rationale and methodology of a study to phenotype patients with COPD in central and eastern Europe[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11:611-622. |
| [5] |
Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish guidelines for management of chronic obstructive pulmonary disease (GesEPOC) 2017. Pharmacological treatment of stable phase[J]. Arch Bronconeumol, 2017, 53(6):324-335.
doi: 10.1016/j.arbres.2017.03.018 URL |
| [6] |
Golpe R, Suárez-Valor M, Martín-Robles I, et al. Mortality in COPD patients according to clinical phenotypes[J]. Int J Chron Obstruct Pulmon Dis, 2018, 13:1433-1439.
doi: 10.2147/COPD URL |
| [7] | 姚锡娟, 马倩, 刘韩韩, 等. 慢性阻塞性肺疾病不同临床表型患病率及临床特征的Meta分析[J]. 重庆医学, 2021, 50(1):126-132. |
| [8] | 黄宇婷, 刘翱. HRCT定量测量与慢性阻塞性肺疾病表型的关系[J]. 中华肺部疾病杂志(电子版), 2015, 8(2):251-253. |
| [9] | 李辉安, 师美娟, 沈聪, 等. 基于体素的COPD早期诊断与CT肺功能定量评估[J]. 西安交通大学学报(医学版), 2019, 40(2):187-192. |
| [10] |
Segal LN, Martinez FJ. Chronic obstructive pulmonary disease subpopulations and phenotyping[J]. J Allergy Clin Immunol, 2018, 141(6):1961-1971.
doi: S0091-6749(18)30332-4 pmid: 29884286 |
| [11] |
Kirby M, Tanabe N, Tan WC, et al. Total airway count on computed tomography and the risk of chronic obstructive pulmonary disease progression. findings from a population-based study[J]. Am J Respir Crit Care Med, 2018, 197(1):56-65.
doi: 10.1164/rccm.201704-0692OC URL |
| [12] |
Fan L, Xia Y, Guan Y, et al. Characteristic features of pulmonary function test, CT volume analysis and MR perfusion imaging in COPD patients with different HRCT phenotypes[J]. Clin Respir J, 2014, 8(1):45-54.
doi: 10.1111/crj.12033 pmid: 23711228 |
| [13] | 王述红, 何正光, 罗晓斌, 等. 慢性阻塞性肺疾病患者胸部高分辨率CT指标分型特征[J]. 现代医院, 2016, 16(4):514-517. |
| [14] | 谭博. 慢性阻塞性肺疾病患者胸部HRCT表型的肺功能和血清生物标志物特征研究[D]. 太原: 山西医科大学, 2016. |
| [15] | Fletcher C, Peto R. The natural history of chronic airflow obstruction[J]. Br Med J, 1977, 1(6077):1645-1648. |
| [16] |
Ji W, Lim MN, Bak SH, et al. Differences in chronic obstructive pulmonary disease phenotypes between non-smokers and smokers[J]. Clin Respir J, 2018, 12(2):666-673.
doi: 10.1111/crj.12577 pmid: 27805311 |
| [17] |
Savran O, Ulrik CS. Early life insults as determinants of chronic obstructive pulmonary disease in adult life[J]. Int J Chron Obstruct Pulmon Dis, 2018, 13:683-693.
doi: 10.2147/COPD URL |
| [18] |
Cho J, Lee CH, Hwang SS, et al. Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke[J]. BMC Pulm Med, 2019, 19(1):68.
doi: 10.1186/s12890-019-0833-7 pmid: 30902075 |
| [19] |
Zhao D, Zhou Y, Jiang C, et al. Small airway disease: A different phenotype of early stage COPD associated with biomass smoke exposure[J]. Respirology, 2018, 23(2):198-205.
doi: 10.1111/resp.13176 pmid: 28906034 |
| [20] |
Adachi H, Derevnina L, Kamoun S. NLR singletons, pairs, and networks: Evolution, assembly, and regulation of the intracellular immunoreceptor circuitry of plants[J]. Curr Opin Plant Biol, 2019, 50:121-131.
doi: S1369-5266(18)30154-7 pmid: 31154077 |
| [21] |
Mincham KT, Bruno N, Singanayagam A, et al. Our evolving view of neutrophils in defining the pathology of chronic lung disease[J]. Immunology, 2021, 164(4):701-721.
doi: 10.1111/imm.13419 pmid: 34547115 |
| [22] |
Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol, 2016, 138(1):16-27.
doi: 10.1016/j.jaci.2016.05.011 pmid: 27373322 |
| [23] |
Hughes MJ, Sapey E, Stockley R. Neutrophil phenotypes in chronic lung disease[J]. Expert Rev Respir Med, 2019, 13(10):951-967.
doi: 10.1080/17476348.2019.1654377 URL |
| [24] |
Negewo NA, McDonald VM, Baines KJ, et al. Peripheral blood eosinophils: A surrogate marker for airway eosinophilia in stable COPD[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11:1495-1504.
doi: 10.2147/COPD URL |
| [25] |
Antus B, Barta I. Blood eosinophils and exhaled nitric oxide: Surrogate biomarkers of airway eosinophilia in stable COPD and exacerbation[J]. Biomedicines, 2022, 10(9):2128.
doi: 10.3390/biomedicines10092128 URL |
| [26] |
David B, Bafadhel M, Koenderman L, et al. Eosinophilic inflammation in COPD:From an inflammatory marker to a treatable trait[J]. Thorax, 2021, 76(2):188-195.
doi: 10.1136/thoraxjnl-2020-215167 URL |
| [27] |
Sivapalan P, Lapperre TS, Janner J, et al. Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): A multicentre, randomised, controlled, open-label, non-inferiority trial[J]. Lancet Respir Med, 2019, 7(8):699-709.
doi: 10.1016/S2213-2600(19)30176-6 pmid: 31122894 |
| [28] |
王晓娟, 方向阳. 慢性阻塞性肺疾病全球倡议2019:慢性阻塞性肺疾病诊断、治疗与预防全球策略解读[J]. 中国全科医学, 2019, 22(18):2141-2149.
doi: 10.12114/j.issn.1007-9572.2019.00.064 |
| [29] |
Martinez-Garcia MA, Faner R, Oscullo G, et al. Inhaled steroids, circulating eosinophils, chronic airway infection, and pneumonia risk in chronic obstructive pulmonary disease. A network analysis[J]. Am J Respir Crit Care Med, 2020, 201(9):1078-1085.
doi: 10.1164/rccm.201908-1550OC URL |
| [30] |
Jabarkhil A, Moberg M, Janner J, et al. Elevated blood eosinophils in acute COPD exacerbations: Better short- and long-term prognosis[J]. Eur Clin Respir J, 2020, 7(1):1757274.
doi: 10.1080/20018525.2020.1757274 URL |
| [31] |
Kandemir Y, Doˇgan NÖ, Yaka E, et al. Clinical characteristics of neutrophilic, eosinophilic and mixed-type exacerbation phenotypes of COPD[J]. Am J Emerg Med, 2021, 45:237-241.
doi: 10.1016/j.ajem.2020.08.044 pmid: 33041140 |
| [1] | Zhao Zhe, Mu Peijuan, Zhang Dong. The efficacy of Endo combined with cisplatin in the treatment of lung cancer complicated with malignant pleural effusion:A meta-analysis [J]. Clinical Focus, 2023, 38(5): 399-404. |
| [2] | Wang Yinlin;Zhang Mingsheng;Zhang Houliang;Liu Yongling. Relationship between alpha angle of pulmonary function curve and BODE index in patients with chronic obstructive pulmonary disease [J]. Clinical Focus, 2015, 30(11): 1254-1.25613e+007. |
| [3] | WANG Xue-feng;ZHANG ji-xian;WANG Yi;DAI Lu-ming;FU Wei-ping. Effects of β2 adrenoceptor genetic polymorphisms on formoterol bronchodilator response in patients with chronic obstructive pulmonary disease [J]. CLINICAL FOCUS, 2009, 24(18): 1578-1581. |
| [4] | . [J]. CLINICAL FOCUS, 2009, 24(14): 1241-1242. |
| [5] | . [J]. CLINICAL FOCUS, 2009, 24(12): 1077-1078. |
| [6] | . [J]. CLINICAL FOCUS, 2006, 21(14): 1018-1019. |
| [7] | . [J]. CLINICAL FOCUS, 2002, 17(2): 84-85. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||